One of the keys to a comfortable retirement is finding a steady and reliable stream of passive income. But Social Security ...

AbbVie on Wednesday said the replicate Phase 3 studies met their co-primary endpoints of reduction in de-pigmentation over the entire body and the face in adults and adolescents with non-segmental ...

AbbVie today announced positive topline results from two replicate Phase 3 studies evaluating the safety and efficacy of upadacitinib (RINVOQ®;15 mg, once daily  in adult and adolescent patients ...

The U.S. Food and Drug Administration is reviewing a new Parkinson's disease drug called tavapadon that could give people ...

Market OverviewThe Global Anti-Aging Market is projected to grow at a CAGR of approximately 5–6% by 2029. The market’s growth is driven by a rising aging population, rapid technological advancements ...

Piramal Pharma Solutions has joined forces with IntoCell to broaden its bioconjugates offering and support innovation in the ...

Allergan Aesthetics, an AbbVie company , today announced the seventh annual BOTOX® Cosmetic Day will take place on Wednesday, ...

REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Thursday, November 6, at 8:00 a.m. ET to discuss its financial results for the third quarter ended September 30, ...

The FDA is planning to speed approvals of highly similar copies of expensive biologic drugs, the latest effort in President ...

A wrist-worn, AI-driven transcutaneous peripheral nerve stimulator is linked to greater improvement in patients with ...

“The focus is to reassess where we stand regarding the pathogenesis and contributing factors for melasma,” Grimes told ...

The vaginal inserts for birth control segment is projected to capture 35.0% of the total market revenue in 2025, emerging as ...